A citation-based method for searching scientific literature

Chau-Ting Yeh, Kung-Hao Liang, Chen-Chun Lin, Ming-Ling Chang, Cheng-Lung Hsu, Chien-Fu Hung. Int J Cancer 2014
Times Cited: 20







List of co-cited articles
88 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL.
Klaus W Wagner, Elizabeth A Punnoose, Thomas Januario, David A Lawrence, Robert M Pitti, Kate Lancaster, Dori Lee, Melissa von Goetz, Sharon Fong Yee, Klara Totpal,[...]. Nat Med 2007
433
50

GALNT14 genotype, α-fetoprotein and therapeutic side effects predict post-chemotherapy survival in patients with advanced hepatocellular carcinoma.
Wey-Ran Lin, Chao-Wei Hsu, Yi-Cheng Chen, Ming-Ling Chang, Kung-Hao Liang, Ya-Hui Huang, Chau-Ting Yeh. Mol Clin Oncol 2014
12
66


GALNT14 genotype effectively predicts the therapeutic response in unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
Kung-Hao Liang, Chih-Lang Lin, Sung-Fang Chen, Chih-Wei Chiu, Pei-Ching Yang, Ming-Ling Chang, Chen-Chun Lin, Kai-Feng Sung, Cassandra Yeh, Chien-Fu Hung,[...]. Pharmacogenomics 2016
13
61

Identification of GALNT14 as a novel neuroblastoma predisposition gene.
Marilena De Mariano, Roberta Gallesio, Marco Chierici, Cesare Furlanello, Massimo Conte, Alberto Garaventa, Michela Croce, Silvano Ferrini, Gian Paolo Tonini, Luca Longo. Oncotarget 2015
29
30

GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy.
Wey-Ran Lin, Jy-Ming Chiang, Kung-Hao Liang, Siew-Na Lim, Ming-Wei Lai, Yung-Kuan Tsou, Tzu-Yun Hsieh, Chih-Kai Hsu, Chau-Ting Yeh. Medicine (Baltimore) 2016
11
54

Sorafenib in advanced hepatocellular carcinoma.
Josep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, Philip Hilgard, Edward Gane, Jean-Frédéric Blanc, Andre Cosme de Oliveira, Armando Santoro, Jean-Luc Raoul, Alejandro Forner,[...]. N Engl J Med 2008
25

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.
Ann-Lii Cheng, Yoon-Koo Kang, Zhendong Chen, Chao-Jung Tsao, Shukui Qin, Jun Suk Kim, Rongcheng Luo, Jifeng Feng, Shenglong Ye, Tsai-Sheng Yang,[...]. Lancet Oncol 2009
25

N-Acetylgalactosaminyltransferase-14 as a potential biomarker for breast cancer by immunohistochemistry.
Chen Wu, Xiaodan Guo, Weina Wang, Yun Wang, Yaojun Shan, Bo Zhang, Wenqian Song, Sisi Ma, Jianfeng Ge, Hao Deng,[...]. BMC Cancer 2010
48
25

GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.
Tian Huanna, Zuo Tao, Wang Xiangfei, An Longfei, Xie Yuanyuan, Wang Jianhua, Zhang Cuifang, Jiao Manjing, Cao Wenjing, Qin Shaochuan,[...]. Mol Carcinog 2015
45
25

Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family.
Eric P Bennett, Ulla Mandel, Henrik Clausen, Thomas A Gerken, Timothy A Fritz, Lawrence A Tabak. Glycobiology 2012
477
25

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray. Int J Cancer 2015
25


GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma.
Yung-Kuan Tsou, Kung-Hao Liang, Wey-Ran Lin, Hsien-Kun Chang, Chen-Kan Tseng, Chau-Ting Yeh. Oncotarget 2017
12
41


Retrospective comparison between a regular and a split-dose protocol of 5-fluorouracil, cisplatin, and mitoxantrone for the treatment of far advanced hepatocellular carcinoma.
Chau-Ting Yeh, Hui-Chin Chen, Chang-Mu Sung, Cheng-Lung Hsu, Chen-Chun Lin, Kuang-Tse Pan, Jeng-Hwei Tseng, Chien-Fu Hung. BMC Cancer 2011
16
25

Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis.
Jae-Hyun Park, Toshihiko Nishidate, Kyoko Kijima, Takao Ohashi, Kaoru Takegawa, Tomoko Fujikane, Koichi Hirata, Yusuke Nakamura, Toyomasa Katagiri. Cancer Res 2010
126
20

Identification of embryonic lethal genes in humans by autozygosity mapping and exome sequencing in consanguineous families.
Hanan E Shamseldin, Maha Tulbah, Wesam Kurdi, Maha Nemer, Nada Alsahan, Elham Al Mardawi, Ola Khalifa, Amal Hashem, Ahmed Kurdi, Zainab Babay,[...]. Genome Biol 2015
63
20

GALNT14 promotes lung-specific breast cancer metastasis by modulating self-renewal and interaction with the lung microenvironment.
Ki-Hoon Song, Mi So Park, Tulip S Nandu, Shrikanth Gadad, Sang-Cheol Kim, Mi-Young Kim. Nat Commun 2016
37
20

Management of hepatocellular carcinoma: an update.
Jordi Bruix, Morris Sherman. Hepatology 2011
15

Toxicity and response criteria of the Eastern Cooperative Oncology Group.
M M Oken, R H Creech, D C Tormey, J Horton, T E Davis, E T McFadden, P P Carbone. Am J Clin Oncol 1982
15

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.
Joseph F Perz, Gregory L Armstrong, Leigh A Farrington, Yvan J F Hutin, Beth P Bell. J Hepatol 2006
15

UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 as a new immunohistochemical breast cancer marker.
Nora Berois, Daniel Mazal, Luis Ubillos, Felipe Trajtenberg, André Nicolas, Xavier Sastre-Garau, Henri Magdelenat, Eduardo Osinaga. J Histochem Cytochem 2006
60
15

Cloning and characterization of a novel UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase, pp-GalNAc-T14.
Han Wang, Kouichi Tachibana, Yan Zhang, Hiroko Iwasaki, Akihiko Kameyama, Lamei Cheng, Jian ming Guo, Toru Hiruma, Akira Togayachi, Takashi Kudo,[...]. Biochem Biophys Res Commun 2003
72
15

N-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancers.
H Dosaka-Akita, I Kinoshita, K Yamazaki, H Izumi, T Itoh, H Katoh, M Nishimura, K Matsuo, Y Yamada, K Kohno. Br J Cancer 2002
36
15

A glycogene mutation map for discovery of diseases of glycosylation.
Lars Hansen, Allan Lind-Thomsen, Hiren J Joshi, Nis Borbye Pedersen, Christian Theil Have, Yun Kong, Shengjun Wang, Thomas Sparso, Niels Grarup, Malene Bech Vester-Christensen,[...]. Glycobiology 2015
36
15

Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival.
Z Li, S Yamada, S Inenaga, T Imamura, Y Wu, K-Y Wang, S Shimajiri, R Nakano, H Izumi, K Kohno,[...]. Br J Cancer 2011
59
15

Mucin-type O-glycosylation during development.
Duy T Tran, Kelly G Ten Hagen. J Biol Chem 2013
164
15



Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer.
Jean-Charles Soria, Zsuzsanna Márk, Petr Zatloukal, Barna Szima, István Albert, Erzsébet Juhász, Jean-Louis Pujol, Jerzy Kozielski, Nigel Baker, Dominic Smethurst,[...]. J Clin Oncol 2011
175
15

Development of immunohistochemistry assays to assess GALNT14 and FUT3/6 in clinical trials of dulanermin and drozitumab.
Howard M Stern, Mary Padilla, Klaus Wagner, Lukas Amler, Avi Ashkenazi. Clin Cancer Res 2010
29
15

All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases.
Kelly G Ten Hagen, Timothy A Fritz, Lawrence A Tabak. Glycobiology 2003
349
15

Prognostic Stratification of Advanced Gastric Signet Ring Cell Carcinoma by Clinicopathological Factors and GALNT14 Genotype.
Tsung-Hsing Chen, Wey-Ran Lin, Chieh Lee, Cheng-Tang Chiu, Jun-Te Hsu, Ta-Sen Yeh, Kwang-Huei Lin, Puo-Hsien Le, Chau-Ting Yeh. J Cancer 2018
9
33

A GALNT14 rs9679162 genotype-guided therapeutic strategy for advanced hepatocellular carcinoma: systemic or hepatic arterial infusion chemotherapy.
Chen-Chun Lin, Chao-Wei Hsu, Yi-Cheng Chen, Ming-Ling Chang, Kung-Hao Liang, Ming-Wei Lai, Chih-Lang Lin, Rong-Nan Chien, Kwang-Huei Lin, Chau-Ting Yeh. Pharmacogenomics J 2020
3
100


Safety and Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma (HCC) and Child-Pugh A versus B Cirrhosis.
Ghassan K Abou-Alfa, Dino Amadori, Armando Santoro, Arie Figer, Jacques De Greve, Chetan Lathia, Dimitris Voliotis, Sibyl Anderson, Marius Moscovici, Sergio Ricci. Gastrointest Cancer Res 2011
80
10

Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis.
T Pressiani, C Boni, L Rimassa, R Labianca, S Fagiuoli, S Salvagni, D Ferrari, E Cortesi, C Porta, C Mucciarini,[...]. Ann Oncol 2013
88
10

Chemotherapy using 5-fluorouracil, mitoxantrone, and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases.
Tsai-Shen Yang, Hsien-Khun Chang, Jen-Shi Chen, Yung-Chang Lin, Chi-Ting Liau, Wen-Cheng Chang. J Gastroenterol 2004
14
14

Medical therapies for hepatocellular carcinoma: a critical view of the evidence.
Augusto Villanueva, Virginia Hernandez-Gea, Josep M Llovet. Nat Rev Gastroenterol Hepatol 2013
241
10

Worse outcome of sorafenib therapy associated with ascites and Child-Pugh score in advanced hepatocellular carcinoma.
Hwi Young Kim, Joong-Won Park, Jungnam Joo, Hyoseok Kim, Sang Myung Woo, Woo Jin Lee, Chang-Min Kim. J Gastroenterol Hepatol 2013
38
10

Prognosis of hepatocellular carcinoma: the BCLC staging classification.
J M Llovet, C Brú, J Bruix. Semin Liver Dis 1999
10

The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis: a retrospective analysis of efficacy, safety, and survival benefits.
Joanne Chiu, Yuen Fong Tang, Tzy-Jyun Yao, Ashley Wong, Hilda Wong, Roland Leung, Pierre Chan, Tan To Cheung, Albert C Chan, Roberta Pang,[...]. Cancer 2012
55
10


TRAIL receptor-targeted therapeutics: resistance mechanisms and strategies to avoid them.
Andrew Thorburn, Kian Behbakht, Heide Ford. Drug Resist Updat 2008
130
10

Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor.
Yao-Ming Wu, Chiung-Hui Liu, Rey-Heng Hu, Miao-Juei Huang, Jian-Jr Lee, Chi-Hau Chen, John Huang, Hong-Shiee Lai, Po-Huang Lee, Wen-Ming Hsu,[...]. Cancer Res 2011
78
10

Expression of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 in gastric mucosa, intestinal metaplasia, and gastric carcinoma.
Joana Gomes, Nuno T Marcos, Nora Berois, Eduardo Osinaga, Ana Magalhães, João Pinto-de-Sousa, Raquel Almeida, Fátima Gärtner, Celso A Reis. J Histochem Cytochem 2009
47
10

Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers.
Kishore Guda, Helen Moinova, Jian He, Oliver Jamison, Lakshmeswari Ravi, Leanna Natale, James Lutterbaugh, Earl Lawrence, Susan Lewis, James K V Willson,[...]. Proc Natl Acad Sci U S A 2009
106
10

ppGalNAc-T13: a new molecular marker of bone marrow involvement in neuroblastoma.
Nora Berois, Etienne Blanc, Hugues Ripoche, Xénia Mergui, Felipe Trajtenberg, Sabrina Cantais, Michel Barrois, Philippe Dessen, Bertil Kågedal, Jean Bénard,[...]. Clin Chem 2006
30
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.